All articles

Viruses at the service of humanity?

Published on 08/03/24 in the following categories Antimicrobials

Once upon a time, the English bacteriologist Ernest Hankin demonstrated for the first time the presence of anti-bacterial entities in the waters of Indian rivers, putting humanity on the path to a promising anti-infectious therapy that is more relevant than ever.

Let’s go back to 1896, on the banks of the Gange, where cholera is ravaging. Hankin, who had been sent to work on the cholera bacillus, was surprised by the small quantity of Vibrio cholerae in the river. He also wondered why, when cholera broke out on the banks, it did not go down to the villages downstream. Since the disease is carried by water, its spread should follow the river. Hankin then revealed the existence of a substance that, even after passing through a Chamberland filter, attacked the bacteria responsible for cholera with formidable efficiency.

This curiosity called out to Félix d’Hérelle, a French researcher who, identified biological entities capable of forming lysis patches on bacterial cultures, in 1917. He simply named these bacteria eaters: “bacteriophages”. The researcher immediately considered using them to treat bacterial infections, and in 1919, he treated a patient suffering from dysentery: phagotherapy was born.

But what was behind these bacteria killers?
It was not until the 1940s that bacteriophages were observed with an electron microscope. Molecular biology then made it possible to discover that they were encapsidated viruses that only attacked bacteria in a very specific and targeted manner. Moreover, it turned out that bacteriophages can be found in all biotopes, even more so if the environment is rich in bacteria, such as soil or sewage. The latter are nowadays privileged places of supply for researchers.

But why has the use of phagotherapy not become more widespread?
To understand this, let’s go back to the 1930s, when the first antibiotics were developed. The widespread use of these very effective molecules in the Western world simply made bacteriophages fall into oblivion…

Today, due to the uncontrolled use of antibiotics, we must face the challenge of antibiotic resistance. The identification of alternative therapies is therefore essential, and it is quite natural that we are once again turning our attention to phagotherapy. Thus, more than a hundred years after their discovery, bacteriophages will finally be able to play their role and express their full potential, providing humanity with a way to avoid returning to a pre-antibiotic era with disastrous consequences.

News and articles

ECCMID – ESCMID Global

Smaltis attends the 34th edition of the ECCMID international congress, renamed ESCMID Global, in Barcelona from April 27 to 30, 2024. This clinical microbiology and infectious diseases event is one of the largest and most important congresses in the field of infection, bringing together over 16,000 participants from all over the world to contribute to the dissemination of scientific knowledge.

READ THE POST

Sanofi Vaccines R&D Day

Smaltis attends the Sanofi Vaccines R&D Day, organized by Sanofi in partnership with Lyonbiopôle, Enosis Santé and Polepharma!
This event aims to foster partnerships around 5 themes: antimicrobial approaches, therapeutic vaccines and antibodies, mucosal or skin delivery of vaccines, immunology, and antigen design. Quite a program!

Cédric Muller will be present at this event, which will take place on April 11, 2024, at 14 Espace Henry Vallée in Lyon.

READ THE POST

Viruses at the service of humanity?

Once upon a time, the English bacteriologist Ernest Hankin demonstrated for the first time the presence of anti-bacterial entities in the waters of Indian rivers, putting humanity on the path to a promising anti-infectious therapy that is more relevant than ever.

READ THE POST

Microbiota & Health Day 7th edition

Smaltis is delighted to be taking part in the 7th edition of Microbiota & Health Day, organized by Lyonbiopôle and Alliance Promotion Microbiote, on March 26, 2024 in Lyon. The aim of this day is to bring together academic, clinical and industrial players to discuss topical issues that are driving innovation in the field of microbiota and their impact on health.

READ THE POST

AMR Conference 8th edition

Smaltis is happy to participate to the 8th edition of AMR Conference in Basel from March 6th to 7th 2024, a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and specific challenges faced by the innovation ecosystem in bringing new antimicrobial treatments and diagnostics to the market.

READ THE POST

The same… But better!

The year 2024 marks the 10th anniversary (already!) of the Smaltis adventure! 10 years of microbiology, 10 years of molecular biology, 10 years of passion, 10 years of twists and turns, 10 years of growth, 10 years of self-reflection, 10 years of continuous improvement, 10 years of scientific spirit, 10 years of ambition, 10 years of collaboration, 10 years of human relationships…

It was necessary to celebrate this milestone, and not just by blowing out the candles.

READ THE POST

The Polepharma Microbiomics Days

Smaltis is delighted to have participated in and sponsored, for the fourth consecutive year, the Polepharma Microbiomics Days, held in Rouen on November 22 and 23, 2023.

READ THE POST

The man who wanted to extend lifespan

Once upon a time, more than a century ago, Elie Metchnikoff hypothesized that health could be improved, and senility delayed by modulating the intestinal microbes thanks to bacteria present in yogurt. This zoologist and microbiologist was thus one of the first scientists to take an interest in gut microbiota and what we now call probiotics, the consumption of which he claimed helped to fight against aging.

This is the story of “the man who wanted to extend lifespan”.

READ THE POST

All our sincere wishes

In this new year that begins, let’s take the time…

Let’s take the time to extend our best wishes to you, from the bottom of our hearts. It seems essential to us, during these periods conducive to gratitude, to prioritize human relationships as the most important aspect of our lives.

READ THE POST